Inclusion Criteria:  Patients who give written informed consent. Type 2 diabetic males & females with age 18 & above years. HbA1c: 7.0% and above. Patients with uncontrolled Diabetes after intervention of lifestyle modifications plus oral and/or insulin therapy.  Exclusion Criteria:  Known type 1 diabetes mellitus patients. History of severe hypoglycemia (<70mg/dL) History of hypersensitivity to any of the active or inactive ingredients of the insulin preparations used in the trial, and/or history of significant allergic drug reactions. Presence of severe diabetes complications. History of renal and/or hepatic dysfunctions. Patients who have been admitted to the hospital in the past 3 months for diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state. History of acute coronary syndrome or stroke. Pregnant or lactating females. History of Acute psychiatric disorder or exacerbation of chronic psychiatric disorder. History or presence of a medical condition or disease that in the investigator's opinion would embarrass glycemic control and completion of the study